HPSE and neoplasm: The probability of survival without recurrence of the neoplastic disease among patients with a post-treatment heparanase concentration higher than 47.14 pg/mL (12.5%) did not differ significantly (log-rank p = 0.3537) with regard to patients with a heparanase concentration lower than 47.14 pg/mL (15%).